Chemoinformaics analysis of 3-Methylbenzaldehyde
| Molecular Weight | 120.151 | nRot | 1 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 7 |
| Exact Molecular Weight | 120.058 | nRing | 1 |
| Solubility: LogS | -2.127 | nHRing | 0 |
| Solubility: LogP | 1.252 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 19.4963 |
| nHD | 0 | BPOL | 8.89366 |
| QED | 0.492 |
| Synth | 2.227 |
| Natural Product Likeliness | 1.086 |
| NR-PPAR-gamma | 0.035 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.05 |
| CACO-2 | -5.858 |
| MDCK | 0.00000436 |
| BBB | 0.049 |
| PPB | 0.719971 |
| VDSS | 0.452 |
| FU | 0.255346 |
| CYP1A2-inh | 0.062 |
| CYP1A2-sub | 0.074 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.257 |
| CYP2c9-sub | 0.157 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.02 |
| CL | 9.109 |
| T12 | 0.939 |
| hERG | 0.024 |
| Ames | 0.097 |
| ROA | 0.028 |
| SkinSen | 0.555 |
| Carcinogencity | 0.034 |
| EI | 0.873 |
| Respiratory | 0.772 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.899946 |